未登录

L

Leonard I. Wiebe

Alexandria University

H指数:31

被引数:4,269

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Synthesis and Preliminary Evaluation of an ASGPr-Targeted Polycationic β-Cyclodextrin Carrier for Nucleosides and Nucleotides

IF5.5

2024-02-260

OAAI

Influence of 2-Nitroimidazoles in the Response of FaDu Cells to Ionizing Radiation and Hypoxia/Reoxygenation Stress

IF6.6

2023-02-063

OAAI

Radiation Dosimetry of Theragnostic Pairs for Isotopes of Iodine in IAZA

IF5.5

2022-08-091

OAAI

Synthesis of [18F]F-γ-T-3, a Redox-Silent γ-Tocotrienol (γ-T-3) Vitamin E Analogue for Image-Based In Vivo Studies of Vitamin E Biodistribution and Dynamics

IF4.6

2020-12-030

OAAI

Putative electron-affinic radiosensitizers and markers of hypoxic tissue: Synthesis and preliminary in vitro biological characterization of C3-amino-substituted benzotriazine dioxides (BTDOs)

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2019-03-012

PREAI

Development of [131I]I-EOE-TPZ and [131I]I-EOE-TPZMO: Novel Tirapazamine (TPZ)-Based Radioiodinated Pharmaceuticals for Application in Theranostic Management of Hypoxia

PHARMACEUTICALS

IF4.8

2019-01-013

OAAI

Pharmacokinetics and Scintigraphic Imaging of the Hypoxia-Imaging Agent [123I]IAZA in Healthy Adults Following Exercise-Based Cardiac Stress

IF5.5

2018-02-223

OAAI

Synthesis and Biological Evaluation of Iodoglucoazomycin (I-GAZ), an Azomycin-Glucose Adduct with Putative Applications in Diagnostic Imaging and Radiotherapy of Hypoxic Tumors

IF3.4

2016-07-056

OAAI

Detecting functional changes with [18F]FAZA in a renal cell carcinoma mouse model following sunitinib therapy

EJNMMI RESEARCH

IF3

2014-09-1016

OAAI

Dosimetric Comparison of the Hypoxia Agent Iodoazomycin Arabinoside (IAZA) Labeled with the Radioisotopes I-123, I-131 and I-124

MEDICAL PHYSICS

IF3.2

2014-05-292

PRE

DETECTING TUMOR HYPOXIA DURING SUNITINIB THERAPY IN A RENAL CELL CARCINOMA MOUSE MODEL USING POSITRON EMISSION TOMOGRAPHY

JOURNAL OF UROLOGY

IF6.8

2013-04-010

PREAI

Design, Synthesis, and Preliminary Biological Evaluation of 6-O-Glucose-Azomycin Adducts for Diagnosis and Therapy of Hypoxic Tumors

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2012-07-0245

PREAI

DETECTION OF FUNCTIONAL CHANGES IN RENAL CELL CARCINOMA WITH POSITRON EMISSION TOMOGRAPHY

JOURNAL OF UROLOGY

IF6.8

2012-04-010

PREAI

Synthesis of hypoxia imaging agent 1-(5-deoxy-5-fluoro-α-D-arabinofuranosyl)-2-nitroimidazole using microfluidic technology

NUCLEAR MEDICINE AND BIOLOGY

IF3

2011-02-0134

PREAI

Confocal laser scanning microscopy (CLSM) based evidence for cell permeation by mono-4-(N-6-deoxy-6-amino-β-cyclodextrin)-7-nitrobenzofuran (NBD-β-CyD)

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2011-01-0113

PREAI

Synthesis, radiofluorination, and hypoxia-selective studies of FRAZ: A configurational and positional analogue of the clinical hypoxia marker, [18F]-FAZA

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2010-03-0111

PRE

Initial results of hypoxia imaging using 1-α-D-(5-deoxy-5-[18F]-fluoroarabinofuranosyl)-2-nitroimidazole (18F-FAZA)

European Journal of Nuclear Medicine and Molecular Imaging

IF7.6

2009-05-09153

PRE

Asialoglycoprotein receptor-targeted superparamagnetic iron oxide nanoparticles

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2008-08-0161

PREAI

5-alkynyl analogs of arabinouridine and 2'-deoxyuridine: Cytostatic activity against herpes simplex virus and varicella-zoster thymidine kinase gene-transfected cells

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2007-05-2346

PREAI

Radiosynthesis, in vitro cellular uptake and in vivo biodistribution of 3′-O-(3-benzenesulfonylfuroxan-4-yl)-5-[125I]iodo-2′-deoxyuridine, a nucleoside-based nitric oxide donor

NUCLEAR MEDICINE AND BIOLOGY

IF3

2005-08-013

PREAI